Repligen Corporation (RGEN)
USD 147.34
(-6.83%)
USD 147.34
(-6.83%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 315.22 Million USD | -37.62% |
| 2022 | 455.7 Million USD | 16.47% |
| 2021 | 391.25 Million USD | 86.64% |
| 2020 | 209.62 Million USD | 38.69% |
| 2019 | 151.14 Million USD | 39.85% |
| 2018 | 108.07 Million USD | 45.69% |
| 2017 | 74.18 Million USD | 29.19% |
| 2016 | 57.42 Million USD | 18.92% |
| 2015 | 48.28 Million USD | 35.92% |
| 2014 | 35.52 Million USD | -17.39% |
| 2013 | 43 Million USD | 22.54% |
| 2012 | 35.09 Million USD | 73.97% |
| 2011 | 20.17 Million USD | 30.45% |
| 2010 | 15.46 Million USD | -31.52% |
| 2009 | 22.58 Million USD | 71.93% |
| 2008 | 13.13 Million USD | 25.59% |
| 2007 | 10.45 Million USD | 11.74% |
| 2006 | 9.36 Million USD | 71.05% |
| 2005 | 5.47 Million USD | 49.28% |
| 2004 | 3.66 Million USD | -14.57% |
| 2003 | 4.29 Million USD | 85.87% |
| 2002 | 2.3 Million USD | 88.68% |
| 2001 | 1.22 Million USD | -54.14% |
| 2000 | 2.66 Million USD | 21.29% |
| 1999 | 2.2 Million USD | 4.76% |
| 1998 | 2.1 Million USD | -40.0% |
| 1997 | 3.5 Million USD | -67.59% |
| 1996 | 10.8 Million USD | -40.0% |
| 1995 | 18 Million USD | -28.85% |
| 1994 | 25.3 Million USD | -8.99% |
| 1993 | 27.8 Million USD | 133.61% |
| 1992 | 11.9 Million USD | 45.12% |
| 1991 | 8.2 Million USD | 272.73% |
| 1990 | 2.2 Million USD | 144.44% |
| 1989 | 900 Thousand USD | -70.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 68.77 Million USD | -8.25% |
| 2024 Q1 | 74.95 Million USD | 10.87% |
| 2023 FY | 284.24 Million USD | -37.62% |
| 2023 Q2 | 79.86 Million USD | -20.78% |
| 2023 Q4 | 67.6 Million USD | 84.93% |
| 2023 Q3 | 36.55 Million USD | -54.22% |
| 2023 Q1 | 100.81 Million USD | 4.95% |
| 2022 Q4 | 96.06 Million USD | -15.9% |
| 2022 FY | 455.7 Million USD | 16.47% |
| 2022 Q2 | 121.37 Million USD | -2.15% |
| 2022 Q1 | 124.04 Million USD | 18.73% |
| 2022 Q3 | 114.22 Million USD | -5.89% |
| 2021 Q1 | 83.09 Million USD | 37.37% |
| 2021 Q4 | 104.47 Million USD | 1.71% |
| 2021 Q3 | 102.72 Million USD | 1.73% |
| 2021 Q2 | 100.97 Million USD | 21.52% |
| 2021 FY | 391.25 Million USD | 86.64% |
| 2020 Q1 | 44.1 Million USD | 12.08% |
| 2020 Q4 | 60.48 Million USD | 11.12% |
| 2020 Q3 | 54.43 Million USD | 7.58% |
| 2020 FY | 209.62 Million USD | 38.69% |
| 2020 Q2 | 50.59 Million USD | 14.72% |
| 2019 Q2 | 39.98 Million USD | 18.33% |
| 2019 FY | 151.14 Million USD | 39.85% |
| 2019 Q1 | 33.78 Million USD | 16.8% |
| 2019 Q4 | 39.35 Million USD | 3.51% |
| 2019 Q3 | 38.02 Million USD | -4.91% |
| 2018 Q4 | 28.92 Million USD | 5.79% |
| 2018 FY | 108.07 Million USD | 45.69% |
| 2018 Q1 | 25.16 Million USD | 11.96% |
| 2018 Q2 | 26.64 Million USD | 5.89% |
| 2018 Q3 | 27.34 Million USD | 2.64% |
| 2017 Q1 | 16.6 Million USD | 23.54% |
| 2017 Q2 | 18.51 Million USD | 11.55% |
| 2017 Q3 | 16.59 Million USD | -10.4% |
| 2017 Q4 | 22.47 Million USD | 35.44% |
| 2017 FY | 74.18 Million USD | 29.19% |
| 2016 FY | 57.42 Million USD | 18.92% |
| 2016 Q1 | 14.02 Million USD | 24.1% |
| 2016 Q2 | 16.52 Million USD | 17.83% |
| 2016 Q3 | 13.43 Million USD | -18.7% |
| 2016 Q4 | 13.43 Million USD | 0.01% |
| 2015 Q3 | 11.37 Million USD | -11.66% |
| 2015 Q2 | 12.87 Million USD | 1.0% |
| 2015 Q4 | 11.3 Million USD | -0.61% |
| 2015 Q1 | 12.74 Million USD | 53.37% |
| 2015 FY | 48.28 Million USD | 35.92% |
| 2014 Q3 | 8.34 Million USD | -6.0% |
| 2014 Q1 | 9.99 Million USD | -0.26% |
| 2014 Q2 | 8.87 Million USD | -11.12% |
| 2014 Q4 | 8.3 Million USD | -0.46% |
| 2014 FY | 35.52 Million USD | -17.39% |
| 2013 Q2 | 11.56 Million USD | 28.79% |
| 2013 Q4 | 10.01 Million USD | -19.47% |
| 2013 Q1 | 8.98 Million USD | -26.82% |
| 2013 FY | 43 Million USD | 22.54% |
| 2013 Q3 | 12.43 Million USD | 7.52% |
| 2012 Q3 | 8.09 Million USD | 5.88% |
| 2012 Q4 | 12.27 Million USD | 51.7% |
| 2012 Q1 | 7.33 Million USD | 0.0% |
| 2012 Q2 | 7.64 Million USD | 4.17% |
| 2012 FY | 35.09 Million USD | 73.97% |
| 2011 FY | 20.17 Million USD | 30.45% |
| 2011 Q4 | - USD | -100.0% |
| 2011 Q2 | 5.68 Million USD | 37.44% |
| 2011 Q1 | 4.13 Million USD | -20.55% |
| 2011 Q3 | 6.12 Million USD | 7.65% |
| 2010 Q3 | 5.45 Million USD | 1.6% |
| 2010 FY | 15.46 Million USD | -31.52% |
| 2010 Q4 | 5.2 Million USD | -4.62% |
| 2010 Q1 | 3.64 Million USD | -13.08% |
| 2010 Q2 | 5.37 Million USD | 47.53% |
| 2009 Q3 | 4.16 Million USD | 19.82% |
| 2009 Q1 | 2.98 Million USD | -32.91% |
| 2009 FY | 22.58 Million USD | 71.93% |
| 2009 Q2 | 3.47 Million USD | 16.45% |
| 2009 Q4 | 4.18 Million USD | 0.68% |
| 2008 Q2 | 11.48 Million USD | 475.1% |
| 2008 FY | 13.13 Million USD | 25.59% |
| 2008 Q1 | 1.99 Million USD | -31.91% |
| 2008 Q3 | 3.66 Million USD | -68.07% |
| 2008 Q4 | 4.44 Million USD | 21.16% |
| 2007 FY | 10.45 Million USD | 11.74% |
| 2007 Q3 | 3.93 Million USD | -7.61% |
| 2007 Q2 | 4.26 Million USD | 52.48% |
| 2007 Q4 | 2.93 Million USD | -25.53% |
| 2007 Q1 | 2.79 Million USD | -9.12% |
| 2006 Q4 | 3.07 Million USD | 57.83% |
| 2006 FY | 9.36 Million USD | 71.05% |
| 2006 Q1 | 1.99 Million USD | -7.95% |
| 2006 Q2 | 2.63 Million USD | 31.92% |
| 2006 Q3 | 1.94 Million USD | -26.01% |
| 2005 FY | 5.47 Million USD | 49.28% |
| 2005 Q4 | 2.17 Million USD | 12.59% |
| 2005 Q3 | 1.92 Million USD | -40.99% |
| 2005 Q2 | 3.26 Million USD | 65.68% |
| 2005 Q1 | 1.97 Million USD | 60.13% |
| 2004 Q2 | 1.67 Million USD | 34.85% |
| 2004 Q1 | 1.24 Million USD | 130.87% |
| 2004 Q3 | 593.1 Thousand USD | -64.63% |
| 2004 Q4 | 1.23 Million USD | 107.58% |
| 2004 FY | 3.66 Million USD | -14.57% |
| 2003 Q2 | 1.2 Million USD | 15.93% |
| 2003 FY | 4.29 Million USD | 85.87% |
| 2003 Q4 | 538.61 Thousand USD | -20.62% |
| 2003 Q3 | 678.48 Thousand USD | -43.71% |
| 2003 Q1 | 1.03 Million USD | -18.52% |
| 2002 Q4 | 1.27 Million USD | 24.42% |
| 2002 FY | 2.3 Million USD | 88.68% |
| 2002 Q1 | 1.02 Million USD | 72.46% |
| 2002 Q2 | 949.79 Thousand USD | -7.41% |
| 2002 Q3 | 1.02 Million USD | 7.99% |
| 2001 Q4 | 594.79 Thousand USD | 79.08% |
| 2001 Q3 | 332.13 Thousand USD | -6.73% |
| 2001 Q2 | 356.09 Thousand USD | -27.65% |
| 2001 Q1 | 492.21 Thousand USD | 35.85% |
| 2001 FY | 1.22 Million USD | -54.14% |
| 2000 Q3 | 284.98 Thousand USD | -31.83% |
| 2000 Q2 | 418.03 Thousand USD | -45.59% |
| 2000 FY | 2.66 Million USD | 21.29% |
| 2000 Q1 | 768.36 Thousand USD | 9.77% |
| 2000 Q4 | 362.31 Thousand USD | 27.13% |
| 1999 Q2 | 600 Thousand USD | -14.29% |
| 1999 FY | 2.2 Million USD | 4.76% |
| 1999 Q1 | 700 Thousand USD | 75.0% |
| 1999 Q4 | 700 Thousand USD | -12.5% |
| 1999 Q3 | 800 Thousand USD | 33.33% |
| 1998 Q2 | 600 Thousand USD | 50.0% |
| 1998 Q1 | 400 Thousand USD | -42.86% |
| 1998 Q3 | 700 Thousand USD | 16.67% |
| 1998 FY | 2.1 Million USD | -40.0% |
| 1998 Q4 | 400 Thousand USD | -42.86% |
| 1997 Q4 | 700 Thousand USD | 75.0% |
| 1997 Q3 | 400 Thousand USD | -42.86% |
| 1997 Q2 | 700 Thousand USD | -22.22% |
| 1997 Q1 | 900 Thousand USD | 0.0% |
| 1997 FY | 3.5 Million USD | -67.59% |
| 1996 FY | 10.8 Million USD | -40.0% |
| 1996 Q4 | 900 Thousand USD | -18.18% |
| 1996 Q3 | 1.1 Million USD | 83.33% |
| 1996 Q2 | 600 Thousand USD | -33.33% |
| 1996 Q1 | 900 Thousand USD | -60.87% |
| 1995 Q1 | 5.3 Million USD | 35.9% |
| 1995 FY | 18 Million USD | -28.85% |
| 1995 Q4 | 2.3 Million USD | -51.06% |
| 1995 Q3 | 4.7 Million USD | 62.07% |
| 1995 Q2 | 2.9 Million USD | -45.28% |
| 1994 FY | 25.3 Million USD | -8.99% |
| 1994 Q4 | 3.9 Million USD | 5.41% |
| 1994 Q2 | 5.1 Million USD | -10.53% |
| 1994 Q1 | 5.7 Million USD | -6.56% |
| 1994 Q3 | 3.7 Million USD | -27.45% |
| 1993 Q3 | 6.9 Million USD | 11.29% |
| 1993 Q4 | 6.1 Million USD | -11.59% |
| 1993 Q2 | 6.2 Million USD | -36.08% |
| 1993 Q1 | 9.7 Million USD | 120.45% |
| 1993 FY | 27.8 Million USD | 133.61% |
| 1992 Q3 | 5.5 Million USD | -40.22% |
| 1992 Q4 | 4.4 Million USD | -20.0% |
| 1992 FY | 11.9 Million USD | 45.12% |
| 1992 Q1 | 4.7 Million USD | 67.86% |
| 1992 Q2 | 9.2 Million USD | 95.74% |
| 1991 Q2 | -400 Thousand USD | -104.49% |
| 1991 Q1 | 8.9 Million USD | 3066.67% |
| 1991 FY | 8.2 Million USD | 272.73% |
| 1991 Q3 | -1 Million USD | -150.0% |
| 1991 Q4 | 2.8 Million USD | 380.0% |
| 1990 Q2 | -100 Thousand USD | -102.33% |
| 1990 Q4 | -300 Thousand USD | 0.0% |
| 1990 FY | 2.2 Million USD | 144.44% |
| 1990 Q3 | -300 Thousand USD | -200.0% |
| 1990 Q1 | 4.3 Million USD | 19.44% |
| 1989 FY | 900 Thousand USD | -70.0% |
| 1989 Q4 | 3.6 Million USD | 33.33% |
| 1989 Q3 | 2.7 Million USD | 8.0% |
| 1989 Q2 | 2.5 Million USD | 13.64% |
| 1989 Q1 | 2.2 Million USD | -18.52% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 56.3 Million USD | -459.858% |
| AngioDynamics, Inc. | 154.69 Million USD | -103.77% |
| AtriCure, Inc. | 300.37 Million USD | -4.947% |
| Avinger, Inc. | 2 Million USD | -15637.793% |
| Azenta, Inc. | 263.14 Million USD | -19.795% |
| BioLife Solutions, Inc. | 46.75 Million USD | -574.256% |
| The Cooper Companies, Inc. | 2.35 Billion USD | 86.631% |
| Daxor Corporation | 1.1 Million USD | -28467.752% |
| Ekso Bionics Holdings, Inc. | 9.07 Million USD | -3372.056% |
| Femasys Inc. | 691.9 Thousand USD | -45459.697% |
| GlucoTrack, Inc. | -13 Thousand USD | 2424930.769% |
| Harvard Bioscience, Inc. | 60.86 Million USD | -417.905% |
| Hologic, Inc. | 2.22 Billion USD | 85.85% |
| ICU Medical, Inc. | 739.87 Million USD | 57.394% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | 93.335% |
| KORU Medical Systems, Inc. | 16.7 Million USD | -1786.657% |
| LeMaitre Vascular, Inc. | 127.04 Million USD | -148.115% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 264267.135% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 264267.135% |
| Masimo Corporation | 1 Billion USD | 68.587% |
| Microbot Medical Inc. | -106 Thousand USD | 297484.906% |
| Meihua International Medical Technologies Co., Ltd. | 33.09 Million USD | -852.494% |
| Merit Medical Systems, Inc. | 583.87 Million USD | 46.011% |
| Nephros, Inc. | 8.4 Million USD | -3650.482% |
| NovoCure Limited | 381.05 Million USD | 17.276% |
| NEXGEL, Inc. | 619 Thousand USD | -50825.363% |
| NEXGEL, Inc. | 619 Thousand USD | -50825.363% |
| Singular Genomics Systems, Inc. | -558 Thousand USD | 56592.473% |
| OraSure Technologies, Inc. | 179.42 Million USD | -75.692% |
| Pro-Dex, Inc. | 14.55 Million USD | -2066.367% |
| Pulse Biosciences, Inc. | -1.2 Million USD | 26216.653% |
| Predictive Oncology Inc. | 1.14 Million USD | -27423.69% |
| Precision Optics Corporation, Inc. | 5.79 Million USD | -5337.049% |
| QuidelOrtho Corporation | 1.49 Billion USD | 78.906% |
| Sanara MedTech Inc. | 57.13 Million USD | -451.704% |
| STAAR Surgical Company | 252.65 Million USD | -24.768% |
| Sharps Technology, Inc. | -891.24 Thousand USD | 35469.28% |
| Utah Medical Products, Inc. | 30.03 Million USD | -949.431% |
| DENTSPLY SIRONA Inc. | 2.08 Billion USD | 84.888% |
| Jin Medical International Ltd. | 6.78 Million USD | -4546.068% |